Literature DB >> 9632704

Leukocystatin, a new Class II cystatin expressed selectively by hematopoietic cells.

S Halfon1, J Ford, J Foster, L Dowling, L Lucian, M Sterling, Y Xu, M Weiss, M Ikeda, D Liggett, A Helms, C Caux, S Lebecque, C Hannum, S Menon, T McClanahan, D Gorman, G Zurawski.   

Abstract

We describe a new cystatin in both mice and humans, which we termed leukocystatin. This protein has all the features of a Class II secreted inhibitory cystatin but contains lysine residues in the normally hydrophobic binding regions. As determined by cDNA library Southern blots, this cystatin is expressed selectively in hematopoietic cells, although fine details of the distribution among these cell types differ between the human and mouse mRNAs. In addition, we have determined the genomic organization of mouse leukocystatin, and we found that in contrast to most cystatins, the leukocystatin gene contains three introns. The recombinant proteins corresponding to these cystatins were expressed in Escherichia coli as N-terminal glutathione S-transferase or FLAGTM fusions, and studies showed that they inhibited papain and cathepsin L but with affinities lower than other cystatins. The unique features of leukocystatin suggests that this cystatin plays a role in immune regulation through inhibition of a unique target in the hematopoietic system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632704     DOI: 10.1074/jbc.273.26.16400

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  The role of cystatins in tick physiology and blood feeding.

Authors:  Alexandra Schwarz; James J Valdés; Michalis Kotsyfakis
Journal:  Ticks Tick Borne Dis       Date:  2012-04-20       Impact factor: 3.744

Review 2.  Endolysosomal proteases and their inhibitors in immunity.

Authors:  Phillip I Bird; Joseph A Trapani; José A Villadangos
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

Review 3.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

4.  Internalization of exogenous cystatin F supresses cysteine proteases and induces the accumulation of single-chain cathepsin L by multiple mechanisms.

Authors:  Jeff D Colbert; Stephen P Matthews; Janko Kos; Colin Watts
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

5.  Cystatin F acts as a mediator of immune suppression in glioblastoma.

Authors:  Emanuela Senjor; Milica Perišić Nanut; Barbara Breznik; Ana Mitrović; Jernej Mlakar; Ana Rotter; Andrej Porčnik; Tamara Lah Turnšek; Janko Kos
Journal:  Cell Oncol (Dordr)       Date:  2021-06-29       Impact factor: 6.730

6.  Synthetic virus-like particles target dendritic cell lipid rafts for rapid endocytosis primarily but not exclusively by macropinocytosis.

Authors:  Rajni Sharma; Arin Ghasparian; John A Robinson; Kenneth C McCullough
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

7.  Cystatins in immune system.

Authors:  Spela Magister; Janko Kos
Journal:  J Cancer       Date:  2012-12-20       Impact factor: 4.207

8.  Glycosylation directs targeting and activation of cystatin f from intracellular and extracellular sources.

Authors:  Jeff D Colbert; Anna Plechanovová; Colin Watts
Journal:  Traffic       Date:  2009-01-24       Impact factor: 6.215

9.  Expression profiling of circulating non-red blood cells in embryonic blood.

Authors:  Brendan A S McIntyre; Cantas Alev; Hiroshi Tarui; Lars M Jakt; Guojun Sheng
Journal:  BMC Dev Biol       Date:  2008-02-27       Impact factor: 1.978

10.  Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages.

Authors:  Courtney Beers; Karen Honey; Susan Fink; Katherine Forbush; Alexander Rudensky
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.